Vir Biotechnology, Inc. (VIR) Return on equity 2019–2025
Vir Biotechnology, Inc. (VIR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-57.2%FY2025 · since FY2019: -41.2% → -57.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -57.2% | -11.9 pp |
| FY2024 | -45.4% | -6.7 pp |
| FY2023 | -38.7% | -63.5 pp |
| FY2022 | 24.8% | -12.1 pp |
| FY2021 | 36.9% | +78.6 pp |
| FY2020 | -41.7% | -0.5 pp |
| FY2019 | -41.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice